Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophy.

@article{Nadarajah2012InfectiousCO,
  title={Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophy.},
  author={Jeyaseelan Nadarajah and Micaela Collins and Janet M. Raboud and Desheng Su and Kavya Rao and Mona Loutfy and Sharon L. Walmsley},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2012},
  volume={55 11},
  pages={
          1568-74
        }
}
BACKGROUND Human immunodeficiency virus (HIV)-related facial lipoatrophy is a devastating adverse effect of antiretroviral therapy. At this time, the most viable treatment option is cosmetic surgery with synthetic fillers. Bio-Alcamid has many advantages over other fillers, and has become widely used. The objective of this study was to determine the incidence rate of infectious complications associated with Bio-Alcamid facial filler in patients with HIV-related facial lipoatrophy (FLA… 

Figures and Tables from this paper

Delayed Onset of Infection Development after Polyalkylimide Treatment for HIV-Associated Lipoatrophy
TLDR
In HIV-patients who received this treatment, immediate therapy within zero to six weeks proved more beneficial in reducing facial lipoatrophy compared to the delayed therapy within twelve to eighteen weeks.
An Overview of Infections Associated With Soft Tissue Facial Fillers: Identification, Prevention, and Treatment.
  • E. Ferneini, D. Beauvais, S. Aronin
  • Medicine
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • 2017
Treating peripheral facial fat loss in patients with human immunodeficiency virus
TLDR
Poly-I-lactic acid injections is one of the treatment options available and allows for facial contours and volume to be restored while being minimally invasive.
HIV-associated lipodystrophy: a review from a Brazilian perspective
TLDR
Clinical presentation, diagnosis, and management of body shape and metabolic complications of HIV infection from a Brazilian perspective is reviewed, a medium income country with a large number of patients on antiretroviral therapy.
Commentary on: Complications After Facial Injections With Permanent Fillers: Important Limitations and Considerations of MRI Evaluation.
  • Z. Lorenc
  • Medicine
    Aesthetic surgery journal
  • 2014
TLDR
The use of magnetic resonance imaging (MRI) as an investigative tool in the assessment of delayed-onset complications subsequent to injections of permanent fillers is proposed to be helpful in assessing filler-related complications where it is difficult to clinically assess the nature and extent of the complication.
Embolization of Bio-Alcamid Gluteal Injections in a Female Patient with Patent Foramen Ovale Leading to ARDS and Embolic Stroke
TLDR
A thirty-one-year-old female who presents with cough, dyspnea, hemoptysis, fever, and pleuritic chest pain several hours after receiving Bio-Alcamid gluteal injections develops acute respiratory failure requiring intubation and is poorly responsive when sedation is held.
Radiolabelled white blood cell scintigraphy in the work-up of dermal filler complications
TLDR
Scintigraphy with radiolabelled WBC was found to be the most accurate method for diagnosing infection in patients with long-term dermal filler complications, particularly using qualitative analysis of SPECT images.
More than just filler: an empirically informed ethical analysis of non-surgical cosmetic procedures in body dysmorphic disorder
TLDR
Ethical analysis suggests that it is generally not in the best interests of individuals with BDD to undergo non-surgical cosmetic intervention, and referral to mental health services is indicated.
...
...

References

SHOWING 1-10 OF 42 REFERENCES
Preliminary Experiences with Bio-Alcamid in HIV Facial Lipoatrophy
TLDR
Bio-Alcamid is considered to be a safe and useful correcting tool for patients suffering from drug-induced facial lipoatrophy and one of the greatest advantages of this filler is that, although permanent, it can be removed easily.
Use of Hyaluronic Acid for Soft Tissue Augmentation of HIV‐Associated Facial Lipodystrophy
  • M. Gooderham, N. Solish
  • Medicine
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2005
TLDR
The use of hyaluronic acid as an intradermal filler for HIV-associated facial lipoatrophy is proposed as an efficacious and safe, but temporary, option for this problem until a more cost-effective option is available.
Cheek Augmentation With Bio-Alcamid in Facial Lipoatrophy in HIV Seropositive Patients
  • J. Hönig
  • Medicine
    The Journal of craniofacial surgery
  • 2008
TLDR
The present study strongly suggests that Bio-Alcamid is suitable for the correction of remarkable defects of facial atrophy, otherwise treatable only by surgery with myofascial free flaps, and permits a simplification of facial reconstruction and rejuvenation.
Experience in the treatment of HIV-associated lipodystrophy.
  • L. Nelson, K. Stewart
  • Medicine
    Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • 2008
Use of a Biopolymer Polyalkylimide Filler for Facial Lipodystrophy in HIV‐Positive Patients Undergoing Treatment with Antiretroviral Drugs
  • P. Treacy, D. Goldberg
  • Medicine
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2006
TLDR
The efficacy, ease of injection, and safety profile of polyalkylimide gel make this filling material a potentially attractive treatment for lipodystrophy, but these data must be tempered with the need for significant further safety studies to determine whether this long-term filler has a safety profile consistent with other currently popular fillers.
Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy.
TLDR
The high patient satisfaction and the low number of severe complications after at least 4 years of facial infiltrations with Aquamid reflect the long-term safety of this product for the repair of facial lipoatrophy.
Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients
TLDR
Treatment with PAIG was effective and safe and led to improvements in facial lipoatrophy grading, QoL, anxiety and depression scores in HIV-infected patients with facial lipboatrophy.
Surgical correction of HIV-associated facial lipoatrophy
TLDR
Earlier detection and treatment of HIV infection, as well as the use of antiretroviral drugs with less deleterious effects on body fat, make it reasonable to hypothesize a decrease in prevalence of lipodystrophy in the coming years.
Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy
TLDR
Treatment with PAIG was associated with sustained improvements in both the physical and psychological components of FLA through 96 weeks of follow-up, with significant improvements in patient's anxiety, depression, and mental health.
Long-Term Effect of Polyalkylimide Gel Injections on Severity of Facial Lipoatrophy and Quality of Life of HIV-Positive Patients
TLDR
Individualized volumes of polyalkylimide gel injected in one session significantly decreased the subjective severity of lipoatrophy and improved the quality of life of HIV-positive patients with grade 2 and 3 lipoat rophy, even in the four patients who had complications.
...
...